Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Growth of Pharmaceutical Industry in Emerging Economies
4.3.2 Commodity Value of Glass Increased with Recyclability
4.4 Market Restraints
4.4.1 Increased Relevance of Alternate Sources
4.5 Industry Value Chain Analysis
4.6 Industry Attractiveness - Porter’s Five Force Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers/Consumers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitute Products
4.6.5 Intensity of Competitive Rivalry
4.7 Assessment of Impact of Covid-19 on the Industry


5 MARKET SEGMENTATION
5.1 Product
5.1.1 Bottles
5.1.2 Vials
5.1.3 Ampoules
5.1.4 Catridges & Syringes
5.1.5 Others Products
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Rest of Asia-Pacific
5.2.4 Latin America
5.2.4.1 Brazil
5.2.4.2 Argentina
5.2.4.3 Rest of Latin America
5.2.5 Middle East and Africa
5.2.5.1 Saudi Arabia
5.2.5.2 South Africa
5.2.5.3 Rest of Middle East and Africa


6 COMPETITIVE LANDSCAPE
6.1 Company Profile?s
6.1.1 Gerresheimer Glass Inc.
6.1.2 Corning Incorporated
6.1.3 Nipro Corporation
6.1.4 SGD S.A (SGD Pharma)
6.1.5 Stolzle-Oberglas GmBH (CAG Holding Gmbh)
6.1.6 Bormioli Pharma S.p.A?
6.1.7 West Pharmaceutical Services, Inc.
6.1.8 Schott AG
6.1.9 Shandong Medicinal Glass Co., Ltd.
6.1.10 Beatson Clark
6.1.11 Arab Pharmaceutical Glass Co.
6.1.12 Piramal Enterprises
6.1.13 ?i?ecam Group


7 INVESTMENT ANALYSIS


8 MARKET OPPORTUNITIES AND FUTURE TRENDS